Overview
Updated: Aug 7, 2026
Company Overview
REDNVIA
REDNVIA focuses on drug repurposing for cardiovascular diseases, particularly developing Suganon for aortic valve calcification treatment.
Address
Headquarters :11F, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, [05505] Republic of Korea
Research Center :-
Website
Class
PharmaceuticalPartnering Goals
Private